Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

VALET data show superiority of valsartan/HCTZ vs. monotherapy in elderly hypertensive patients

May 12, 2010

Humenza well tolerated and immunogenic in children

May 11, 2010

Phase III and other data on morphine/oxycodone combination reported

May 11, 2010

Proof-of-concept study in irritable bowel disease encourages larger studies with AST-120

May 11, 2010

Phase I safety data reported for orphan drug QPI-1002

May 11, 2010

Wnt signaling inhibitor CW-232291 to advance to phase I

May 11, 2010

CTS-1027 well tolerated in HCV patients failing prior treatments

May 11, 2010

Prostate cancer diagnostic 99mTc-EC-0652 to proceed to phase 0 clinical evaluation

May 11, 2010

Novel "two-in-one" antibody targeting EGFR/HER3 shows preclinical potential

May 11, 2010

Improvements seen with gene therapy in small study in severe retinal dystrophy

May 10, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...